- Home
- HOTH vs LSTA Comparison
HOTH vs LSTA Comparison
Compare HOTH & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- LSTA
- Stock Information
- Founded
- HOTH 2017
- LSTA 1980
- Country
- HOTH United States
- LSTA United States
- Employees
- HOTH N/A
- LSTA N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- LSTA Misc Health and Biotechnology Services
- Sector
- HOTH Health Care
- LSTA Health Care
- Exchange
- HOTH Nasdaq
- LSTA Nasdaq
- Market Cap
- HOTH 18.0M
- LSTA 20.9M
- IPO Year
- HOTH 2019
- LSTA N/A
- Fundamental
- Price
- HOTH $1.16
- LSTA $1.96
- Analyst Decision
- HOTH Strong Buy
- LSTA Strong Buy
- Analyst Count
- HOTH 2
- LSTA 2
- Target Price
- HOTH $4.50
- LSTA $23.50
- AVG Volume (30 Days)
- HOTH 316.4K
- LSTA 142.1K
- Earning Date
- HOTH 11-12-2025
- LSTA 11-06-2025
- Dividend Yield
- HOTH N/A
- LSTA N/A
- EPS Growth
- HOTH N/A
- LSTA N/A
- EPS
- HOTH N/A
- LSTA N/A
- Revenue
- HOTH N/A
- LSTA $1,070,000.00
- Revenue This Year
- HOTH N/A
- LSTA N/A
- Revenue Next Year
- HOTH N/A
- LSTA N/A
- P/E Ratio
- HOTH N/A
- LSTA N/A
- Revenue Growth
- HOTH N/A
- LSTA N/A
- 52 Week Low
- HOTH $0.66
- LSTA $1.81
- 52 Week High
- HOTH $3.80
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- HOTH 38.64
- LSTA 32.56
- Support Level
- HOTH $1.14
- LSTA $1.81
- Resistance Level
- HOTH $1.22
- LSTA $2.13
- Average True Range (ATR)
- HOTH 0.08
- LSTA 0.18
- MACD
- HOTH -0.01
- LSTA -0.03
- Stochastic Oscillator
- HOTH 38.57
- LSTA 22.22
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.